Abstract
A pilot study on the use of a continuous infusion of somatostatin, by subcutaneous pumps in the management of proliferative diabetic retinopathy is reported. Two patients out of eight with proliferative retinopathy demonstrated improvement. One patient demonstrated regression of disc new vessels and the other a reduced area of retinal capillary non-perfusion, both demonstrated by fluorescein angiography. Control patients showed worsening of fluorescein leakage over the observation period of four to six weeks whereas the other six patients given the somatostatin infusion did not demonstrate any deterioration.
The mechanism of action of somatostatin in this study is unknown but it is thought to have direct anti-angiogenic properties as well as inhibiting growth hormone secretion.
Similar content being viewed by others
Article PDF
References
Lundbaek K, Malmos R, Andersen HC, Rasmussen JH, Bruntse E, Madsen PH, Jensen VA : Hypophysectomy for diabetic angiopathy: a controlled clinical trial. In Goldberg MF, and Fine SL, eds: Symposium on the treatment of diabetic retinopathy, US Public Health Service Pub no 1890 Washington DC, 1969, US Government Printing Office.
Merrimee TJ : A follow-up study of vascular disease in growth hormone deficient dwarfs with diabetes. N Engl J Med 1978, 298: 1217–22.
Passa R, Rousselie F, Gauville C, Canivet J : Retinopathy and plasma growth hormone levels in idiopathic haemochromatosis with diabetes. Diabetes 1977, 26: 113–20.
Kohner EM, Joplin GF, Blach RK, Cheng H, Fraser TR : Pituitary ablation in the treatment of diabetic retinopathy (a randomised trial). Trans Ophthalmol Soc UK 1972, 92: 79–90.
Poulsen JE : Recovery from retinopathy in a case of diabetes with Simmond's disease. Diabetes 1953, 2: 7–12.
Rizza RA, Mandarino LJ, Gerich JE : Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilisation. Diabetes 1982, 31: 663–9.
Gerich JE, Lorenzi M, Bier DM : Effects of physiological levels of glucagon and growth hormone on human carbohydrate and lipid metabolism: studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with Somatostatin. J Clin Invest 1976, 57: 875–84.
Hansen AP and Johansen K : Diurnal patterns of blood glucose, serum fatty acids, glucagon and growth hormone in normals and juvenile diabetics. Diabetologia 1970, 6: 27–33.
Adams D, Rand R, Roth N, Dashe A, Gipstein R, Heuse G : Hypophysectomy in diabetic retinopathy. The relationship between degree of pituitary ablation and ocular response. Diabetes 1974, 23: 698–707.
Wright AD, Kohner EM, Oakley NW, Hartog M, Joplin GF, Fraser TR : Serum GH and the response of diabetic retinopathy to pituitary ablation. Br Med J 1969, 2: 246–8.
Holly JMP, Amiel SA, Sandhu RR, Rees LH, Wass JAH : The role of growth hormone in diabetes mellitus. J Endocrinol 1988, 118: 353–64.
Passa P, Gauville C, Canivet J : Influences of muscular exercise on plasma level of growth hormone in diabetics with and without retinopathy. Lancet 1974, 2: 72–4.
Gerich JE : Rationale for inhibition of growth hormone secretion in the management of the diabetic patient. Scand J Gastroenterol (Suppl) 1986, 119: 154–7.
Plewe G, Noelken G, Krause U, Beyer J, del Pozo E : Suppression of growth hormone and somato-medin C by long-acting somatostatin analogue SMS 201-995 in type 1 diabetes mellitus. Hormone Res 1987, 27: 7 12.
Gerich JE, Lorenzi M, Schneider V, Karam JH, Rivier J, Guillemin R, Forsham PH : Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. New Engl J Med 1974, 291: 544–7.
Gerich JE, Schultz TA, Lewis SB, Karam JH : Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitus. Diabetologia 1977, 13: 537–44.
Wahren J and Felig P : Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus. Lancet 1976, 2: 1213–16.
Hall R, Besser GM, Sehally AV : Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet 1973, 2: 581–4.
Hyer SL, Sharp PS, Brooks RA, Burrin JM, Kohner EM : Continuous subcutaneous octreotide infusion markedly suppresses IGF-1 levels whilst only partially suppressing GH secretion in diabetics with retinopathy. Acta Endocrinol (Copenhagen) 1989, 120: 187–94.
Diabetic Retinopathy Study Research Group: Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976, 81: 383–96.
Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy: the second report of Diabetic Retinopathy Study findings. Ophthalmology 1978, 85: 82–106.
Diabetic Retinopathy Study Research Group: Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report no. 8. Invest Ophthalmol Vis Sci 1981, 88: 583–600.
Sassolas G, Khalfallah Y, Chayvaille JA : Effects of the Somatostatin analogue BIM 23014 on the secretion of growth hormone, thyrotropin and digestive peptides in normal men. J Clin Endocrinol Metab 1989, 68: 239–46.
Kuhn JM, Basin C, Molard M, Rouge de B, Wolf LM : Effects of the new somatostatin analog (B/M 20314) on glucose homeostasis in normal men. The Endocrine Society, 72nd Annual Meeting. June 1990 p 51 (abstract).
Diabetic Retinopathy Study Research Group: Indications for photocoagulation treatment of diabetic retinopathy: DRS Report No. 14. Int Ophthalmol Clin 1987 (Winter); 27(4): 239–53.
McDonald HR and Schatz H : Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1985, 92: 388–93.
Higgins KE, Meyers SM, Jaffe MJ, Roy MS, Monasterio FM : Temporary loss of foveal contrast sensitivity associated with panretinal photo-coagulation. Arch Ophthalmol 1986, 104: 997–1003.
Woltering EA, Barrie R, O'Doriso TM, Arce D, Ure T, Cramer A, Holmes D, Robertson J, Fass-ler J : Somatostatin analogues inhibit angiogenesis in the chick allantoic membrane. Digestion 1990. 8th International symposium on Gastro-intestinal Hormones p 123.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCombe, M., Lightman, S., Eckland, D. et al. Effect of a long-acting somatostatin analogue (BIM23014) on proliferative diabetic retinopathy: A pilot study. Eye 5, 569–575 (1991). https://doi.org/10.1038/eye.1991.99
Issue Date:
DOI: https://doi.org/10.1038/eye.1991.99
Keywords
This article is cited by
-
Medical treatment of diabetic retinopathy
Eye (2003)